688217 Shanghai Rightongene Biotechnology
- 21.13
- -0.03-0.14%
Shanghai Rightongene Biotechnology News
Announcement of Resolutions of the 20th Meeting of the 2nd Supervisory Board of Ruion Genetics
Fund Raising Management System (October 2024)
Information Disclosure Management System (October 2024)
Investor Relations Management System (October 2024)
Measures for managing the Company\'s shares held by directors, supervisors and senior management and their changes (October 2024)
Verification opinions of Guotai Junan Securities Co., Ltd. on the progress of important matters of Shanghai Ruiang Gene Technology Co., Ltd.
Guotai Junan Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shanghai Ruian Gene Technology Co., Ltd.
Ruion Gene Investor Relations Activity Record Form for September 10, 2024 (2024 Semi-Annual Results Briefing)
Announcement of Ruion Gene on holding the 2024 semi-annual results briefing
Ruian Gene\'s special report on the storage and actual use of funds raised in the 2024 semi-year
Ruian Gene\'s semi-annual evaluation report on the 2024 “Improve Quality, Increase Efficiency, and Value Return” Special Action Plan
Announcement of Resolutions of the 19th Meeting of the 2nd Supervisory Committee of Ruian Gene
Announcement of Resolutions of the 26th Meeting of the 2nd Board of Directors of Ruian Gene
Opinion on the verification of major matters of Shanghai Ruiai Gene Technology Co., Ltd. by gtja Securities Co., Ltd.
Shanghai Rightongene Biotechnology: Announcement of Significant Matters from Ruiang Genetics.
Shanghai Rightongene Biotechnology: Announcement of resolutions passed in the 25th meeting of the second board of directors of Ruiangene.
Investor relations activity record of Rayon Gene on June 7, 2024.
Ruion Genomics Investor Relations Activity Record Form for May 28, 2024
Announcement of Ryon Genomics on receiving government subsidies
Opinions of Guotai Junan Securities Co., Ltd. on the initial public offering of some restricted shares of Shanghai Ruian Gene Technology Co., Ltd. and the lifting of the listing and circulation ban
Analysis
Price Target
No Data
No Data